CE
Celanese Corporation
NYSE · Basic Materials · Chemicals · US
$45.24
+0.09%Year over year
Reported trailing growth
- Revenue
- -2.3%
- EBITDA
- -32.2%
- EBIT
- +9.8%
- EPS
- +27.9%
- Free cash flow
- +12.0%
- Operating cash flow
- -3.5%
Forward estimates
Based on analyst estimates
- Revenue
- +3.6%
- EBITDA
- +920.6%
- EPS
- +154.6%
Three-year CAGR
- Revenue
- -0.4%
- EBITDA
- -49.8%
- EBIT
- -17.7%
- Net income
- +23.5%
- EPS
- +23.6%
- Free cash flow
- -14.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026